Form 4: NeuroPace Chief Medical Officer Disposes Shares for Tax Obligations
Insider Transaction Report
NeuroPace Inc.'s Chief Medical Officer, Martha Morrell, reported the disposition of 1,338 shares of common stock to cover tax withholding obligations related to equity vesting.
Summary
- Martha Morrell, Chief Medical Officer of NeuroPace Inc. (NPCE), reported a transaction on June 3, 2025.
- She disposed of 1,338 shares of NeuroPace Common Stock.
- The disposition was made at a price of $13.54 per share.
- This transaction was coded as 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
- Following this transaction, Ms. Morrell beneficially owns 85,943 shares of NeuroPace Common Stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine disposition for tax purposes, which is neutral in sentiment. It reflects the vesting of equity compensation rather than a discretionary sale.
Future Outlook
This Form 4 filing pertains to a past transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing is a routine insider transaction related to equity compensation and does not provide specific insights into broader industry trends or competitive dynamics within the medical device or neuroscience sectors. Such transactions are common across all industries for executives receiving equity-based compensation.
Comparison to Industry Standards
- NA. This Form 4 reports a standard insider transaction for tax withholding purposes, which is a common practice across publicly traded companies when equity awards vest. It does not provide financial or operational results that can be compared to industry benchmarks or specific competitors.
Stakeholder Impact
- Shareholders: The disposition of a small number of shares for tax purposes by an executive is a routine event and is unlikely to have a significant direct impact on shareholders, beyond the minor dilution inherent in equity compensation programs.
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of transaction where shares were disposed. |
| 06/06/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
NeuroPace Inc, NPCE, Form 4, Insider Transaction, Martha Morrell, Chief Medical Officer, Stock Disposition, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.